“Research scientists are openly protesting against a recent motion to ban stem cell patent protection, which could possibly block stem-cell research in Europe. On 10 March, Yves Bot, advocate-general of the European Court of Justice, spoke out against current patents that allow research using embryonic stem cells. Bot argued that it was unethical and immoral to patent human cells for commercial use …” (more)
[Lily Panamsky, The Journal, 4 May]